NLRP3 inflammasome-mediated choroid plexus hypersecretion contributes to hydrocephalus after intraventricular

Zhaoqi Zhang1,2,3, Qiang Tan1,2,3, Peiwen Guo1,2,3

  • 1Department of Neurosurgery and State Key Laboratory of Trauma, Burn and Combined Injury, Southwest Hospital, Third Military Medical University (Army Medical University), 29 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.

Insights

The NLRP3 inflammasome drives cerebrospinal fluid (CSF) overproduction after brain hemorrhage, leading to hydrocephalus. Inhibiting NLRP3 reduces CSF secretion and brain swelling, offering a new therapeutic target for hydrocephalus.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathophysiology

Background:

  • Hydrocephalus is a severe complication of intracerebral hemorrhage with ventricular extension (ICH-IVH), causing cerebrospinal fluid (CSF) accumulation.
  • The choroid plexus epithelium is crucial for CSF secretion and the brain-immune interface.
  • The role of the NLRP3 inflammasome in ICH-IVH-induced hydrocephalus was previously unknown.

Purpose of the Study:

  • To investigate the role of the NLRP3 inflammasome in the pathogenesis of hydrocephalus following ICH-IVH.
  • To explore the potential mechanism of NLRP3 inflammasome activation in CSF hypersecretion.
  • To identify NLRP3 as a potential therapeutic target for hydrocephalus.

Main Methods:

  • Developed a rat model of hydrocephalus after ICH-IVH using autologous blood infusion.
  • Utilized wild-type and Nlrp3 knockout rats for comparative analysis.
  • Performed RNA-sequencing and proteomics on choroid plexus tissue, alongside in vitro experiments.

Main Results:

  • ICH-IVH rats exhibited ventricular dilation and CSF hypersecretion, with peak NLRP3 inflammasome component expression at 3 days post-hemorrhage.
  • Inhibition of NLRP3 (via MCC950 or knockout) reduced CSF secretion, ventricular dilation, and neurological deficits.
  • NLRP3 inhibition decreased NKCC1 phosphorylation, implicating the NLRP3/p-NKCC1 pathway and ion flux in CSF regulation.

Conclusions:

  • NLRP3 inflammasome activation promotes CSF hypersecretion in the choroid plexus epithelium post-hemorrhage.
  • The NLRP3/p-NKCC1 pathway is a key mechanism in hydrocephalus pathogenesis after ICH-IVH.
  • Targeting the NLRP3 inflammasome presents a novel therapeutic strategy for hydrocephalus.
Abstract

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...